Request for Covid-19 Impact Assessment of this Report
The United States Anti-Neprilysin Antibody market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Anti-Neprilysin Antibody market, reaching US$ million by the year 2028. As for the Europe Anti-Neprilysin Antibody landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Anti-Neprilysin Antibody players cover Bioprojet SCR, Novartis International AG, Pharmaleads SA, and Theravance Biopharma Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Neprilysin Antibody market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Sacubitril
TD-0714
STR-324
PL-265
LHW-090
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bioprojet SCR
Novartis International AG
Pharmaleads SA
Theravance Biopharma Inc.
Cipla Limited
Oceanic Pharmachem Pvt. Ltd
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-Neprilysin Antibody Market Size 2017-2028
2.1.2 Anti-Neprilysin Antibody Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Anti-Neprilysin Antibody Segment by Type
2.2.1 Sacubitril
2.2.2 TD-0714
2.2.3 STR-324
2.2.4 PL-265
2.2.5 LHW-090
2.3 Anti-Neprilysin Antibody Market Size by Type
2.3.1 Anti-Neprilysin Antibody Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Anti-Neprilysin Antibody Market Size Market Share by Type (2017-2022)
2.4 Anti-Neprilysin Antibody Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Anti-Neprilysin Antibody Market Size by Application
2.5.1 Anti-Neprilysin Antibody Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Anti-Neprilysin Antibody Market Size Market Share by Application (2017-2022)
3 Anti-Neprilysin Antibody Market Size by Player
3.1 Anti-Neprilysin Antibody Market Size Market Share by Players
3.1.1 Global Anti-Neprilysin Antibody Revenue by Players (2020-2022)
3.1.2 Global Anti-Neprilysin Antibody Revenue Market Share by Players (2020-2022)
3.2 Global Anti-Neprilysin Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Anti-Neprilysin Antibody by Regions
4.1 Anti-Neprilysin Antibody Market Size by Regions (2017-2022)
4.2 Americas Anti-Neprilysin Antibody Market Size Growth (2017-2022)
4.3 APAC Anti-Neprilysin Antibody Market Size Growth (2017-2022)
4.4 Europe Anti-Neprilysin Antibody Market Size Growth (2017-2022)
4.5 Middle East & Africa Anti-Neprilysin Antibody Market Size Growth (2017-2022)
5 Americas
5.1 Americas Anti-Neprilysin Antibody Market Size by Country (2017-2022)
5.2 Americas Anti-Neprilysin Antibody Market Size by Type (2017-2022)
5.3 Americas Anti-Neprilysin Antibody Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Neprilysin Antibody Market Size by Region (2017-2022)
6.2 APAC Anti-Neprilysin Antibody Market Size by Type (2017-2022)
6.3 APAC Anti-Neprilysin Antibody Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Anti-Neprilysin Antibody by Country (2017-2022)
7.2 Europe Anti-Neprilysin Antibody Market Size by Type (2017-2022)
7.3 Europe Anti-Neprilysin Antibody Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-Neprilysin Antibody by Region (2017-2022)
8.2 Middle East & Africa Anti-Neprilysin Antibody Market Size by Type (2017-2022)
8.3 Middle East & Africa Anti-Neprilysin Antibody Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Anti-Neprilysin Antibody Market Forecast
10.1 Global Anti-Neprilysin Antibody Forecast by Regions (2023-2028)
10.1.1 Global Anti-Neprilysin Antibody Forecast by Regions (2023-2028)
10.1.2 Americas Anti-Neprilysin Antibody Forecast
10.1.3 APAC Anti-Neprilysin Antibody Forecast
10.1.4 Europe Anti-Neprilysin Antibody Forecast
10.1.5 Middle East & Africa Anti-Neprilysin Antibody Forecast
10.2 Americas Anti-Neprilysin Antibody Forecast by Country (2023-2028)
10.2.1 United States Anti-Neprilysin Antibody Market Forecast
10.2.2 Canada Anti-Neprilysin Antibody Market Forecast
10.2.3 Mexico Anti-Neprilysin Antibody Market Forecast
10.2.4 Brazil Anti-Neprilysin Antibody Market Forecast
10.3 APAC Anti-Neprilysin Antibody Forecast by Region (2023-2028)
10.3.1 China Anti-Neprilysin Antibody Market Forecast
10.3.2 Japan Anti-Neprilysin Antibody Market Forecast
10.3.3 Korea Anti-Neprilysin Antibody Market Forecast
10.3.4 Southeast Asia Anti-Neprilysin Antibody Market Forecast
10.3.5 India Anti-Neprilysin Antibody Market Forecast
10.3.6 Australia Anti-Neprilysin Antibody Market Forecast
10.4 Europe Anti-Neprilysin Antibody Forecast by Country (2023-2028)
10.4.1 Germany Anti-Neprilysin Antibody Market Forecast
10.4.2 France Anti-Neprilysin Antibody Market Forecast
10.4.3 UK Anti-Neprilysin Antibody Market Forecast
10.4.4 Italy Anti-Neprilysin Antibody Market Forecast
10.4.5 Russia Anti-Neprilysin Antibody Market Forecast
10.5 Middle East & Africa Anti-Neprilysin Antibody Forecast by Region (2023-2028)
10.5.1 Egypt Anti-Neprilysin Antibody Market Forecast
10.5.2 South Africa Anti-Neprilysin Antibody Market Forecast
10.5.3 Israel Anti-Neprilysin Antibody Market Forecast
10.5.4 Turkey Anti-Neprilysin Antibody Market Forecast
10.5.5 GCC Countries Anti-Neprilysin Antibody Market Forecast
10.6 Global Anti-Neprilysin Antibody Forecast by Type (2023-2028)
10.7 Global Anti-Neprilysin Antibody Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Bioprojet SCR
11.1.1 Bioprojet SCR Company Information
11.1.2 Bioprojet SCR Anti-Neprilysin Antibody Product Offered
11.1.3 Bioprojet SCR Anti-Neprilysin Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bioprojet SCR Main Business Overview
11.1.5 Bioprojet SCR Latest Developments
11.2 Novartis International AG
11.2.1 Novartis International AG Company Information
11.2.2 Novartis International AG Anti-Neprilysin Antibody Product Offered
11.2.3 Novartis International AG Anti-Neprilysin Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis International AG Main Business Overview
11.2.5 Novartis International AG Latest Developments
11.3 Pharmaleads SA
11.3.1 Pharmaleads SA Company Information
11.3.2 Pharmaleads SA Anti-Neprilysin Antibody Product Offered
11.3.3 Pharmaleads SA Anti-Neprilysin Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pharmaleads SA Main Business Overview
11.3.5 Pharmaleads SA Latest Developments
11.4 Theravance Biopharma Inc.
11.4.1 Theravance Biopharma Inc. Company Information
11.4.2 Theravance Biopharma Inc. Anti-Neprilysin Antibody Product Offered
11.4.3 Theravance Biopharma Inc. Anti-Neprilysin Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Theravance Biopharma Inc. Main Business Overview
11.4.5 Theravance Biopharma Inc. Latest Developments
11.5 Cipla Limited
11.5.1 Cipla Limited Company Information
11.5.2 Cipla Limited Anti-Neprilysin Antibody Product Offered
11.5.3 Cipla Limited Anti-Neprilysin Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Cipla Limited Main Business Overview
11.5.5 Cipla Limited Latest Developments
11.6 Oceanic Pharmachem Pvt. Ltd
11.6.1 Oceanic Pharmachem Pvt. Ltd Company Information
11.6.2 Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Antibody Product Offered
11.6.3 Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Oceanic Pharmachem Pvt. Ltd Main Business Overview
11.6.5 Oceanic Pharmachem Pvt. Ltd Latest Developments
12 Research Findings and Conclusion
Table 1. Anti-Neprilysin Antibody Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Sacubitril
Table 3. Major Players of TD-0714
Table 4. Major Players of STR-324
Table 5. Major Players of PL-265
Table 6. Major Players of LHW-090
Table 7. Anti-Neprilysin Antibody Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Anti-Neprilysin Antibody Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Anti-Neprilysin Antibody Market Size Market Share by Type (2017-2022)
Table 10. Anti-Neprilysin Antibody Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Anti-Neprilysin Antibody Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Anti-Neprilysin Antibody Market Size Market Share by Application (2017-2022)
Table 13. Global Anti-Neprilysin Antibody Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Anti-Neprilysin Antibody Revenue Market Share by Player (2020-2022)
Table 15. Anti-Neprilysin Antibody Key Players Head office and Products Offered
Table 16. Anti-Neprilysin Antibody Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Anti-Neprilysin Antibody Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Anti-Neprilysin Antibody Market Size Market Share by Regions (2017-2022)
Table 21. Americas Anti-Neprilysin Antibody Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Anti-Neprilysin Antibody Market Size Market Share by Country (2017-2022)
Table 23. Americas Anti-Neprilysin Antibody Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Anti-Neprilysin Antibody Market Size Market Share by Type (2017-2022)
Table 25. Americas Anti-Neprilysin Antibody Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Anti-Neprilysin Antibody Market Size Market Share by Application (2017-2022)
Table 27. APAC Anti-Neprilysin Antibody Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Anti-Neprilysin Antibody Market Size Market Share by Region (2017-2022)
Table 29. APAC Anti-Neprilysin Antibody Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Anti-Neprilysin Antibody Market Size Market Share by Type (2017-2022)
Table 31. APAC Anti-Neprilysin Antibody Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Anti-Neprilysin Antibody Market Size Market Share by Application (2017-2022)
Table 33. Europe Anti-Neprilysin Antibody Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Anti-Neprilysin Antibody Market Size Market Share by Country (2017-2022)
Table 35. Europe Anti-Neprilysin Antibody Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Anti-Neprilysin Antibody Market Size Market Share by Type (2017-2022)
Table 37. Europe Anti-Neprilysin Antibody Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Anti-Neprilysin Antibody Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Anti-Neprilysin Antibody Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Anti-Neprilysin Antibody Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Anti-Neprilysin Antibody Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Anti-Neprilysin Antibody Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Anti-Neprilysin Antibody Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Anti-Neprilysin Antibody Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Anti-Neprilysin Antibody
Table 46. Key Market Challenges & Risks of Anti-Neprilysin Antibody
Table 47. Key Industry Trends of Anti-Neprilysin Antibody
Table 48. Global Anti-Neprilysin Antibody Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Anti-Neprilysin Antibody Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Anti-Neprilysin Antibody Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Anti-Neprilysin Antibody Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Anti-Neprilysin Antibody Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Anti-Neprilysin Antibody Market Size Market Share Forecast by Application (2023-2028)
Table 54. Bioprojet SCR Details, Company Type, Anti-Neprilysin Antibody Area Served and Its Competitors
Table 55. Bioprojet SCR Anti-Neprilysin Antibody Product Offered
Table 56. Bioprojet SCR Anti-Neprilysin Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Bioprojet SCR Main Business
Table 58. Bioprojet SCR Latest Developments
Table 59. Novartis International AG Details, Company Type, Anti-Neprilysin Antibody Area Served and Its Competitors
Table 60. Novartis International AG Anti-Neprilysin Antibody Product Offered
Table 61. Novartis International AG Main Business
Table 62. Novartis International AG Anti-Neprilysin Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Novartis International AG Latest Developments
Table 64. Pharmaleads SA Details, Company Type, Anti-Neprilysin Antibody Area Served and Its Competitors
Table 65. Pharmaleads SA Anti-Neprilysin Antibody Product Offered
Table 66. Pharmaleads SA Main Business
Table 67. Pharmaleads SA Anti-Neprilysin Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Pharmaleads SA Latest Developments
Table 69. Theravance Biopharma Inc. Details, Company Type, Anti-Neprilysin Antibody Area Served and Its Competitors
Table 70. Theravance Biopharma Inc. Anti-Neprilysin Antibody Product Offered
Table 71. Theravance Biopharma Inc. Main Business
Table 72. Theravance Biopharma Inc. Anti-Neprilysin Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Theravance Biopharma Inc. Latest Developments
Table 74. Cipla Limited Details, Company Type, Anti-Neprilysin Antibody Area Served and Its Competitors
Table 75. Cipla Limited Anti-Neprilysin Antibody Product Offered
Table 76. Cipla Limited Main Business
Table 77. Cipla Limited Anti-Neprilysin Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Cipla Limited Latest Developments
Table 79. Oceanic Pharmachem Pvt. Ltd Details, Company Type, Anti-Neprilysin Antibody Area Served and Its Competitors
Table 80. Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Antibody Product Offered
Table 81. Oceanic Pharmachem Pvt. Ltd Main Business
Table 82. Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Oceanic Pharmachem Pvt. Ltd Latest Developments
List of Figures
Figure 1. Anti-Neprilysin Antibody Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-Neprilysin Antibody Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Anti-Neprilysin Antibody Market Size Market Share by Type in 2021
Figure 7. Anti-Neprilysin Antibody in Hospital Pharmacies
Figure 8. Global Anti-Neprilysin Antibody Market: Hospital Pharmacies (2017-2022) & ($ Millions)
Figure 9. Anti-Neprilysin Antibody in Retail Pharmacies
Figure 10. Global Anti-Neprilysin Antibody Market: Retail Pharmacies (2017-2022) & ($ Millions)
Figure 11. Anti-Neprilysin Antibody in Online Pharmacies
Figure 12. Global Anti-Neprilysin Antibody Market: Online Pharmacies (2017-2022) & ($ Millions)
Figure 13. Global Anti-Neprilysin Antibody Market Size Market Share by Application in 2021
Figure 14. Global Anti-Neprilysin Antibody Revenue Market Share by Player in 2021
Figure 15. Global Anti-Neprilysin Antibody Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Anti-Neprilysin Antibody Market Size 2017-2022 ($ Millions)
Figure 17. APAC Anti-Neprilysin Antibody Market Size 2017-2022 ($ Millions)
Figure 18. Europe Anti-Neprilysin Antibody Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Anti-Neprilysin Antibody Market Size 2017-2022 ($ Millions)
Figure 20. Americas Anti-Neprilysin Antibody Value Market Share by Country in 2021
Figure 21. Americas Anti-Neprilysin Antibody Consumption Market Share by Type in 2021
Figure 22. Americas Anti-Neprilysin Antibody Market Size Market Share by Application in 2021
Figure 23. United States Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Anti-Neprilysin Antibody Market Size Market Share by Region in 2021
Figure 28. APAC Anti-Neprilysin Antibody Market Size Market Share by Application in 2021
Figure 29. China Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Anti-Neprilysin Antibody Market Size Market Share by Country in 2021
Figure 36. Europe Anti-Neprilysin Antibody Market Size Market Share by Type in 2021
Figure 37. Europe Anti-Neprilysin Antibody Market Size Market Share by Application in 2021
Figure 38. Germany Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Anti-Neprilysin Antibody Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Anti-Neprilysin Antibody Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Anti-Neprilysin Antibody Market Size Market Share by Application in 2021
Figure 46. Egypt Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Anti-Neprilysin Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 52. APAC Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 53. Europe Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 55. United States Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 56. Canada Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 59. China Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 60. Japan Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 61. Korea Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 63. India Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 64. Australia Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 65. Germany Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 66. France Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 67. UK Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 68. Italy Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 69. Russia Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 70. Spain Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 73. Israel Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Anti-Neprilysin Antibody Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...